TLR4 and metabolic dysfunction-associated steatotic liver disease: Although TLR4 variants are present in patients with MASLD, the specific contribution of Thr399Ile to disease pathology needs to be clarified, as this variant does not appear to affect downstream signaling pathways significantly.